Indazole derivatives as CRF antagonists

3 1 2 This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II: wherein Ris optionally substituted aryl or heteroaryl, Rand Rare as defined in the specification; or individual isomers, racemic or non-racemic mixtures of i...

Full description

Saved in:
Bibliographic Details
Main Authors Cournoyer, Richard Leo, Loughhead, David Garrett, O'Yang, Counde
Format Patent
LanguageEnglish
Published 08.05.2007
Online AccessGet full text

Cover

More Information
Summary:3 1 2 This invention relates to compounds which are generally CRF-1 receptor antagonists and which are represented by Formula I or Formula II: wherein Ris optionally substituted aryl or heteroaryl, Rand Rare as defined in the specification; or individual isomers, racemic or non-racemic mixtures of isomers, or pharmaceutically acceptable salts thereof. The invention further relates to processes for preparing such compounds, to pharmaceutical compositions containing such compounds, and to methods for their use as therapeutic agents.